Drug Pipeline

Quercetin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
5
Recruiting
1
Phase 3
5
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-05 NCT07628972 Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD) Phase 1 Recruiting
Active Studies by Phase
Phase 2/3
1
Phase 2
3
Phase 1/2
1
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05653258 Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older… Obesity Recruiting
Phase 2
NCT06940297 Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or… Recurrent Multiple Myeloma Recruiting
NCT05838560 Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders Schizophrenia Active, Not Recruiting
NCT07144293 Improving Physical Ability and Cellular Senescence Elimination in HIV HIV Active, Not Recruiting
Phase 1/2
NCT04785300 ALSENLITE: Senolytics for Alzheimer's Disease Mild Cognitive Impairment Active, Not Recruiting
Phase 1
NCT07433621 Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency XIAP Deficiency Recruiting
NCT07628972 Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD) Dyskeratosis Congenita Recruiting
Early Phase 1
NCT07025226 Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or… Glioma Recruiting
Sponsors Running Quercetin Trials
Mayo Clinic (3) Children's Hospital Medical Center, Cincinnati (2) Cedars-Sinai Medical Center (1) Washington University School of Medicine (1) National Institute of Allergy and Infectious Diseases (NIAID) (1)
Disease Areas
Alzheimer's Disease (1) Obesity (1) Depression (1) Schizophrenia (1) Multiple Myeloma (1) Glioma (1)
Get alerts when Quercetin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free